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Background: Opioid use in North America has increased rapidly in recent years. Pre
operative opioid use is associated with several negative outcomes. Our objectives were to
assess patterns of opioid use over time in Canadian patients who undergo spine surgery
and to determine the effect of spine surgery on 1-year postoperative opioid use.
Methods: A retrospective analysis was performed on prospectively collected data from
the Canadian Spine Outcomes and Research Network for patients undergoing elective
thoracic and lumbar surgery. Self-reported opioid use at baseline, before surgery and at
1 year after surgery was compared. Baseline opioid use was compared by age, sex, radio
logic diagnosis and presenting complaint. All patients meeting eligibility criteria from
2008 to 2017 were included.
Results: A total of 3134 patients provided baseline opioid use data. No significant change in
the proportion of patients taking daily (range 32.3%–38.2%) or intermittent (range 13.7%–
22.5%) opioids was found from pre-2014 to 2017. Among patients who waited more than
6 weeks for surgery, the frequency of opioid use did not differ significantly between the base
line and preoperative time points. Significantly more patients using opioids had a chief com
plaint of back pain or radiculopathy than neurogenic claudication (p < 0.001), and significantly
more were under 65 years of age than aged 65 years or older (p < 0.001). Approximately 41%
of patients on daily opioids at baseline remained so at 1 year after surgery.
Conclusion: These data suggest that additional opioid reduction strategies are needed
in the population of patients undergoing elective thoracic and lumbar spine surgery.
Spine surgeons can be involved in identifying patients taking opioids preoperatively,
emphasizing the risks of continued opioid use and referring patients to appropriate
evidence-based treatment programs.
Contexte : En Amérique du Nord, l’utilisation d’opioïdes a augmenté rapidement dans
les dernières années. La prise d’opioïdes en période préopératoire est associée à plusieurs
issues négatives. Cette étude visait à évaluer l’évolution des tendances dans l’utilisation
d’opioïdes des patients canadiens ayant subi une chirurgie spinale, et de déterminer les
effets de la chirurgie sur leur utilisation 1 an après l’opération.
Méthodes : Une analyse rétrospective a été réalisée à partir de données recueillies de
manière prospective par le Canadian Spine Outcomes and Research Network pour les
patients ayant subi une chirurgie thoracique ou une chirurgie spinale élective. On a com
paré l’utilisation autodéclarée d’opioïdes au début du suivi, avant la chirurgie et 1 an
après la chirurgie. L’utilisation d’opioïdes au départ a été comparée selon le sexe, l’âge, le
diagnostic radiologique et le motif de consultation. Entre 2008 et 2017, tous les patients
satisfaisant aux critères d’admissibilités ont été inclus dans l’étude.
Résultats : Au total, 3134 patients ont fourni des données sur leur prise d’opioïdes au
début du suivi. Il n’y avait pas de changement significatif dans la proportion de patients
utilisant quotidiennement (32,3 % à 38,2 %) ou occasionnellement (13,7 % à 22,5 %) des
opioïdes entre les patients à l’étude avant 2014 et ceux à l’étude de 2014 à 2017. Parmi les
patients qui ont attendu plus de 6 semaines avant la chirurgie, la fréquence de la prise
d’opioïdes n’a pas changé de manière significative entre le début du suivi et la rencontre
préopératoire. Une proportion significativement plus grande de patients qui utilisaient des
opioïdes consultaient principalement pour des douleurs au dos ou une radiculopathie que
pour une claudication neurogène (p < 0,001), et il y avait une proportion significativement
plus grande de patients de moins de 65 ans qui utilisaient des opioïdes que de patients de
65 ans ou plus (p < 0,001). Environ 41 % des patients qui prenaient quotidiennement des
opioïdes au départ le faisaient aussi 1 an après la chirurgie.
Conclusion : Ces données suggèrent que des stratégies supplémentaires de réduction de
l’utilisation d’opioïdes sont nécessaires pour les patients qui subissent une chirurgie thora
cique ou une chirurgie spinale élective. Il est possible de demander aux chirurgiens spécialisés
dans ce domaine de repérer les patients qui prennent des opioïdes avant l’opération, puisque
l’utilisation prolongée comporte des risques, et de les aiguiller vers un programme de traite
ment adéquat et fondé sur des données probantes.
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pioid use has increased rapidly in the last
20 years in the United States and Canada. 1–3
While previous studies have suggested opioids
are safe and efficacious in patients with spine pathol
ogy,4–6 many health-related and socioeconomic prob
lems associated with opioid use have become apparent.
Recent research in patients who undergo hip and knee
arthroplasty and spinal procedures has indicated that
patients on preoperative opioids have more difficulty
with pain control in the perioperative period, 7,8
increased hospital length of stay (LOS) 9 and worse
postoperative outcomes than patients not regularly
using opioids preoperatively.10–13
It is estimated that nearly one-quarter of patients who
undergo orthopedic surgery and 19% of patients who
undergo neurosurgery are on opioids preoperatively.14 In
Canada, there is a lack of research documenting the pro
portion of patients presenting to tertiary spine surgery
clinics who are taking opioids. To our knowledge, no
publication has investigated whether increased physician
awareness of the adverse effects associated with regular
opioid usage has resulted in fewer patients being pre
scribed opioids for spine-related pain.
Recent clinical guidelines have recommended against
opioid use for the management of low-back pain.15 A
recent randomized controlled trial indicated that treat
ment with opioids was not superior to treatment with
nonopioid medications for improving pain-related func
tion over 12 months in patients with moderate to severe
chronic back pain.16
The aims of this study were to determine the propor
tion of patients presenting to tertiary spine surgery clin
ics in Canada who indicated opioid use, examine trends
over time and investigate 1-year postoperative opioid
use. Ultimately, our goal was to evaluate the need for
surgeons to be proactive in addressing opioid use and
reducing harms associated with opioid prescribing.17 The
authors hypothesize that, owing to the increase in media
attention regarding opioid use and physician awareness
of associated risks, a decrease in opioid use will be
observed during the study period.

Methods
Study design
We conducted a multicentre, retrospective review of
consecutive patients undergoing thoracic and lumbar
spine surgery who were enrolled by the Canadian
Spine Outcomes and Research Network (CSORN)
between October 2008 and August 2017. The network
is a group of more than 50 neurosurgical and orthope
dic spine surgeons from 18 tertiary care academic and
nona cademic hospitals across Canada that prospec
tively collects data on patients with spinal conditions

on an ongoing and voluntary basis. This database
serves as a national registry, which was created to
answer research questions and to facilitate the imple
mentation of best practices.
A national database research coordinator audits
data quality and performance and sends reports to
each contributing hospital site coordinator on a
quarterly basis. Reports track data completion and
follow-up rates to facilitate internal data validation at
each site. A national privacy and security framework
was created for CSORN that includes a governance
structure, standard operating procedures, training
processes, physical and technical security and privacy
impact assessments. This model ensures that personal
health information is kept private and secure. Writ
ten informed consent is obtained from all partici
pating patients. Patient information is anonymized to
ensure that patients in the network cannot be indi
vidually identified. Twelve sites contributed to this
specific project. Each site obtained research ethics
board approval before any data collection. Decisions
regarding data collection, storage and analysis are
independent of any particular company or commer
cial interest.
Patient sample
Local research coordinators enrolled eligible patients
at each site. To be eligible, patients had to be 18 years
of age or older and must have undergone elective sur
gery involving the thoracic and/or lumbar spine
(decompression or decompression and fusion) and
answered the question pertaining to opioid pain medi
cation on the baseline questionnaire. Exclusion cri
teria were as follows: emergency cases, fractures, revi
sion surgery, tumour, surgery at cervical levels and a
chief complaint other than back pain, neurogenic clau
dication and/or radiculopathy. Chief complaint was
documented by the surgeon at the time the surgical
procedure was booked. Patients were asked to report
opioid use at the initial visit with a spine surgeon
(baseline), preoperatively (if the surgical date was
more than 6 weeks after the initial visit) and at 1-year
postoperative follow-up.
Patient variables
Baseline preoperative patient characteristics included
sociodemographic factors, use of opioid and nonopioid
medications, comorbidities, symptom duration and
symptom intensity. The specific focus of this study was
on the question “Do you take opioid pain medication
for your back problem?” Examples of generic opioids
were provided. The response choices were “never,”
“intermittent” or “daily.”
Can J Surg/J can chir 2020;63(3)
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Study measures
The treating surgeons recorded operative and postop
erative variables including type of procedure, number
of levels, chief complaint and primary radiologic diag
nosis. Research coordinators collected patientreported outcomes and information on medication use
at baseline, preoperatively (> 6 wk from baseline,
before surgery) and 12 months postoperatively. The
additional preoperative data point was reported by
only 5 of the 12 sites because of limitations in the
availability of staff resources. Data were collected in
person, via post or through an emailed hyperlink to an
online patient portal.
Statistical analysis

sex: 36.5% of women used opioids daily, 20.7% used
them intermittently and 42.8% never used them,
whereas 32.4% of men used opioids daily, 18.9% used
them intermittently and 48.8% never used them (p =
0.42). There was also no significant difference in opi
oid use by symptom duration: 43.7% of patients who
had had symptoms for less than 2 years and 46.7% of
patients who had had symptoms for 2 or more years
never used opioids (p = 0.11). Significantly more
patients under age 65 years were taking opioids, com
pared with those aged 65 years or older (p < 0.001;
Fig. 2). Significantly fewer patients with a chief com
plaint consistent with neurogenic claudication were
taking opioid medications than those with radiculo
pathy or back pain (p < 0.001; Fig. 3).
Table 1. Baseline characteristics of patients

The registry started as a pilot at 1 site in 2008, expanded
to 3 sites in 2012 and gradually grew over the subse
quent years to encompass 18 sites; patients who had sur
gery between 2008 and 2013 were grouped together for
the analysis owing to the relatively small number of
patients in the early years of the database. Opioid use
was stratified by year (pre-2014, then annually through
to and including 2017) at baseline, preoperatively in
those patients who waited longer than 6 weeks after
their initial visit for surgery, at 1 year postoperatively,
and by chief complaint, age and primary radiologic
diagnosis. χ2 testing, with significance set a priori at 5%,
was used to compare opioid use by enrolment year, time
point (baseline presentation, preoperative and 1-year
postoperative), sex, age, symptom duration, radiologic
diagnosis and chief complaint. Patients with both base
line and preoperative data were compared using pairedsamples t tests to assess the impact of an extended wait
time before surgery.

Results
Of the 4267 patients who met the inclusion criteria,
26.6% did not provide complete baseline data on opi
oid use. Thus, the evaluated sample was 3134 patients.
There were no differences in age, sex, number of lev
els or symptom duration between patients who
answered the question on opioid use and those who
did not. Table 1 provides baseline characteristics for
the sample population.
A total of 34.5% of the patients reported daily opi
oid use, 19.8% intermittent use and 45.8% no opioid
use. There was no change in the proportion of opioid
use over time (p = 0.39; Fig. 1): the proportion of
patients taking opioids daily ranged from 32.3% to
38.2%, and the proproportion of patients taking opi
oids intermittently ranged from 13.7% to 22.5%.
There was no significant difference in opioid use by
E308
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Characteristic
Sex, % male

Patients who did
not use opioids

Patients who used
opioids

54.3

48.3

60.8 ± 14.4 (18–89)

56.2 ± 14.5 (18–89)

< 65 yr

52.9

67.9

≥ 65 yr

47.1

32.1

Deformity

4.6

4.3

Degenerative disc disease

5.1

9.0

Disc herniation

17.2

27.6

Spondylolisthesis

37.3

28.8

Stenosis

35.8

30.3

Back pain

11.5

14.8

Neurogenic claudication

46.5

34.0

Radiculopathy

42.0

51.1

Decompression alone

38.3

33.5

Decompression and fusion

61.7

66.5

1

63.6

61.8

2

21.7

21.6

≥3

14.6

16.6

Age, yr, mean ± SD (range)
Age, % of patients

Diagnosis, % of patients

Chief complaint, % of patients

Type of surgery, % of patients

No. of surgical levels,
% of patients

No. of comorbidities,
% of patients
0

10.3

6.5

1

21.8

19.6

2

22.6

20.3

≥3

45.3

53.6

< 1 yr

18.6

23.3

1–2 yr

16.2

14.3

≥ 2 yr

65.2

62.4

Back

6.42 ± 2.45 (0–10)

7.28 ± 2.13 (0–10)

Leg

7.06 ± 2.26 (0–10)

7.5 ± 2.1 (0–10)

Symptom duration,
% of patients

Numeric pain rating,
mean ± SD (range)

SD = standard deviation.
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Significantly more patients with a primary radio
logic diagnosis of degenerative disc disease were taking
opioids (67.6%) than those with a primary diagnosis of
deformity, spondylolisthesis or stenosis (p < 0.01;
Fig. 4). Similarly, significantly more patients with a
primary radiologic diagnosis of disc herniation
reported taking opioids (65.4%) than those with a pri
mary diagnosis of deformity, spondylolisthesis or sten
osis (p < 0.01; Fig. 4).
At 5 of the 12 sites, updated questionnaires were
administered to patients who waited longer than 6 weeks
for surgery. Analysis of these data (for 895 patients)
revealed no significant difference in the proportions of
opioid use between the baseline and preoperative time
points (at baseline 37.2% of patients reported daily use,
60

Percentage of patients

50

40

30

21.9% reported intermittent use and 41.0% reported no
use of opioids; at the preoperative time point 36.8%
reported daily use, 21.6% reported intermittent use and
41.7% reported no use of opioids; p > 0.05).
Of the 3134 patients in this study, 2329 passed the
1-year mark from surgery and were eligible for 1-year
follow-up; 1624 were reached for follow-up (69.7%).
Within this cohort, at 1-year postoperative follow-up
there was a significant decrease in the proportion of
patients taking daily opioids from baseline (34.7% to
16.9%, p < 0.01) and an increase in the proportion of
patients not taking opioids (45.8% to 71.4%, p < 0.01;
Fig. 5). Of the patients not taking opioids at baseline, at
1-year follow-up, 3.9% reported taking opioids daily and
5.4% intermittently; 676 (90.7%) did not take opioids at
baseline nor at 1-year follow-up.
Of the patients taking intermittent
Daily
or daily opioids at baseline, 54.7%
Intermittent
Never
reported taking no opioids at
1-year follow up. Of the patients
who took opioids daily at baseline,
13.8% went down to intermittent
use and 45.7% reported taking no
opioids at 1-year follow-up.

Discussion
20

10

0

Pre-2014

2014

2015

2016

2017

Year of assessment

Fig. 1. Opioid use at baseline by year.

80

90

Daily or intermittent opioids
No opioids

70

*

*

70

Percentage of patients

Percentage of patients

Daily or intermittent opioids
No opioids

80

60
50
40
30
20
10
0

With data from the CSORN, we
investigated the proportions of
patients undergoing spine sur
gery who used opioids and the
concomitant changes in opioid
use over time. Fifty-two percent
of patients presenting to Canad
ian tertiary spine surgery clinics

50
40
30
20
10
0

< 65

≥ 65

Age (yr)

Fig. 2. Opioid use at baseline by age. *Denotes significant difference (p < 0.001).

*

60

Back pain

Radiculopathy

Chief complaint

Neurogenic
claudication

Fig. 3. Opioid use at baseline by chief complaint. *Denotes significant difference (p < 0.001).
Can J Surg/J can chir 2020;63(3)
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Percentage of patients

Percentage of patients

At 1 year after surgery,
daily opioid use among our
Daily or intermittent opioids
patient population was signifi
100
No opioids
cantly lower than at the time
*
90
*
of the initial visit with the
*
80
*
spine surgeon; however,
70
*
*
almost 30% of patients con
60
tinued to take opioids on a
50
daily or intermittent basis.
40
Nearly half of patients (45%)
who were taking opioids
30
before surgery remained on
20
opioids at 1-year follow-up,
10
and, alarmingly, nearly 10%
0
of patients who were opioid
Deformity
DDD
Disc herniation
Spondylolithesis
Stenosis
naïve before surgery were
Primary diagnosis
found to be taking opioids
Fig. 4. Opioid use at baseline by primary diagnosis. Patients in the stenosis category did not 1 year after surgery.
have spondylolisthesis. *Denotes significant difference (p < 0.01). DDD = degenerative disc
A recent study by Dunn
disease.
and colleagues investigated
opioid use in patients undergoing elective spinal fusion
of 2 levels or more at a university hospital in the United
80
*
States.20 They found that 72% of patients were taking
Baseline
70
1-yr postoperative follow-up
opioids before surgery. In comparison, 54% of patients
60
in our study were taking opioids at the first assessment
50
with a spine surgeon. The greater proportion of
*
40
patients taking opioids preoperatively in the study by
30
Dunn and colleagues may reflect a difference in inclu
20
sion criteria (i.e., all elective thoracic and lumbar sur
10
gery cases versus elective spinal fusions of 2 levels or
0
more). Nonetheless, 52% of those patients taking opi
Daily
Intermittent
Never
oids preoperatively were still taking opioids at 1-year
Opioid use
follow-up, which is similar to the follow-up findings of
our study.20
Fig. 5. Opioid use at baseline versus 1 year postoperatively.
Pugely and colleagues studied patients in the
*Denotes significant difference (p < 0.01).
United States undergoing cervical spine fusion
before 2014 reported taking opioids on a daily or between 2007 and 2014 and found that 52% were
intermittent basis, a finding that was relatively con
taking opioids before surgery. 21 At 1-year follow-up,
sistent across the study period (2008 to 2017). We
45% of patients who had used opioids preopera
found that significantly fewer patients aged 65 years
tively remained on opioids. Both of these results are
and older took preoperative opioids than patients
comparable to the findings of our study. Further
younger than 65 years of age. This is probably attrib more, the authors found preoperative opioid use was
utable to the finding that fewer patients with a radio
associated with an increased likelihood of postoper
logic diagnosis of stenosis and chief complaint of ative opioid use after 12 months, a finding consis
neurogenic claudication were on preoperative opioids
tent with several studies in patients who undergo
than those with other diagnoses, and neurogenic spine surgery. 7,21,22
claudication secondary to stenosis is more common
Regular opioid use in patients who undergo spine
in older patients (average age at the time of surgery surgery is concerning for many reasons, with reported
was 63.8 yr in a Canadian cohort, as compared with associations including inferior clinical outcomes, lower
35.8 yr for radiculopathy).18,19 Another possible rea return to work rates, increased pain intensity in the
son for the difference in opioid use by age is that
perioperative period and increased hospital LOS.8–11,23
neurogenic claudication symptoms tend to be
Our results indicate that approximately 45% of preop
relieved with rest and many patients do not take erative opioid users remained on opioids 1 year after
analgesics for this problem; rather, they modify their their spine surgery. Given this result and the fact that
activities to control symptoms.
preoperative opioid use is a risk factor for continued
E310
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use at 1 year after surgery, there is a need for opioid
reduction strategies and for spine surgeons to assist in
efforts to decrease opioid use preoperatively.
Limitations
Our study relied heavily on data from patient selfadministered questionnaires, and it is therefore subject
to limitations inherent to such surveys, including
skipped answers and misunderstood questions. 24 Our
analysis is also limited to those patients who admitted to
taking opioids for their back problem. It is possible that
a proportion of patients may have chosen not to answer
this question because of a perceived stigma associated
with opioid use. This limitation may have led to an
underreporting bias of opioid use in our patient sample.
Conversely, it is possible that our study overreports the
proportion of patients using opioids by excluding those
who did not specifically answer “none” to the opioids
question even though they were not taking opioids. Fur
thermore, we do not have data on the quantity or dose
of opioids taken by the patients included in this study. A
1-year follow-up rate of 70% is another limitation. It is
possible that many patients for whom we do not have
data at 1 year could have been uncontactable because
they were doing well and were no longer seeking med
ical treatment. However, there are several possible rea
sons for losing patients to follow-up regardless of their
condition. including unwillingness of the patient to be
contacted, a change in contact information or failure of
correspondence.

Conclusion
The prevalence of opioid use in patients who undergo
spine surgery in Canada remains high, with nearly half
of patients who take opioids before surgery remaining
on these medications 1 year after their procedure. There
is an opportunity to improve clinical outcomes by
decreasing opioid use in this population. Spine surgeons
may have a role to play in identifying patients taking
opioids preoperatively, helping to emphasize the risks of
continued opioid use and referring patients to appropri
ate evidence-based treatment programs.
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